Vita 34 AG (XTER:V3V) Marketable Securities : €0.00 Mil (As of Sep. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Vita 34 AG Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Vita 34 AG's Marketable Securities for the quarter that ended in Sep. 2023 was €0.00 Mil.

Vita 34 AG's annual Marketable Securities increased from Dec. 2020 (€0.12 Mil) to Dec. 2021 (€2.08 Mil) but then declined from Dec. 2021 (€2.08 Mil) to Dec. 2022 (€1.94 Mil).

Vita 34 AG Marketable Securities Historical Data

The historical data trend for Vita 34 AG's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vita 34 AG Marketable Securities Chart

Vita 34 AG Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Marketable Securities

Get a 7-Day Free Trial

0.13

0.12

2.08

1.94

Vita 34 AG Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Marketable Securities	Get a 7-Day Free Trial															-	1.94	-	-	-

Vita 34 AG Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Vita 34 AG (XTER:V3V) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Vita 34 AG Marketable Securities Related Terms

Thank you for viewing the detailed overview of Vita 34 AG's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Vita 34 AG (XTER:V3V) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Vita 34 AG (XTER:V3V) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

V3V:Germany V3V:Germany V3V:Germany

Address

Deutscher Platz 5a, Leipzig, DEU, D-04103

Website

https://www.vita34.de

Vita 34 AG is an umbilical cord blood bank. It supplies cryo-preservation and provides for the logistics to collect the blood, the preparation and the storage of stem cells from umbilical cord blood and tissue. The Group has two strategic areas that constitute the Group's reportable segments. Both segments are active in the field of stem cell banking, but differ in their organizational and operational structure with separate financial information. The products and services of the two segments correspond to the service portfolios of the two subgroups PBKM and Vita 34. It operates in Germany, Spain, and other international countries, of which maximum revenue is derived from the business operations in Germany.

Executives

Jakub Julian Baran	Member of the Management Board
Dr. Alexander Granderath	Supervisory Board

Vita 34 AG (XTER:V3V) Headlines

No Headlines